Literature DB >> 33579926

Impact of the COVID-19 nonpharmaceutical interventions on influenza and other respiratory viral infections in New Zealand.

Q Sue Huang1, Tim Wood2, Lauren Jelley2, Tineke Jennings3, Sarah Jefferies2, Karen Daniells2, Annette Nesdale3, Tony Dowell4, Nikki Turner5, Priscilla Campbell-Stokes3, Michelle Balm6, Hazel C Dobinson6, Cameron C Grant5, Shelley James6, Nayyereh Aminisani2, Jacqui Ralston2, Wendy Gunn2, Judy Bocacao2, Jessica Danielewicz2, Tessa Moncrieff2, Andrea McNeill2, Liza Lopez2, Ben Waite2, Tomasz Kiedrzynski7, Hannah Schrader2, Rebekah Gray2, Kayla Cook2, Danielle Currin2, Chaune Engelbrecht3, Whitney Tapurau3, Leigh Emmerton3, Maxine Martin3, Michael G Baker4, Susan Taylor8, Adrian Trenholme8, Conroy Wong8, Shirley Lawrence8, Colin McArthur9, Alicia Stanley9, Sally Roberts9, Fahimeh Rahnama9, Jenny Bennett10, Chris Mansell10, Meik Dilcher11, Anja Werno11, Jennifer Grant12, Antje van der Linden12, Ben Youngblood13, Paul G Thomas13, Richard J Webby13.   

Abstract

Stringent nonpharmaceutical interventions (NPIs) such as lockdowns and border closures are not currently recommended for pandemic influenza control. New Zealand used these NPIs to eliminate coronavirus disease 2019 during its first wave. Using multiple surveillance systems, we observed a parallel and unprecedented reduction of influenza and other respiratory viral infections in 2020. This finding supports the use of these NPIs for controlling pandemic influenza and other severe respiratory viral threats.

Entities:  

Year:  2021        PMID: 33579926     DOI: 10.1038/s41467-021-21157-9

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  1 in total

1.  Decreased Influenza Activity During the COVID-19 Pandemic - United States, Australia, Chile, and South Africa, 2020.

Authors:  Sonja J Olsen; Eduardo Azziz-Baumgartner; Alicia P Budd; Lynnette Brammer; Sheena Sullivan; Rodrigo Fasce Pineda; Cheryl Cohen; Alicia M Fry
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2020-09-18       Impact factor: 17.586

  1 in total
  81 in total

Review 1.  Acute hepatitis (Non Hepa A-E) of unknown origin among pediatrics.

Authors:  Nasim Asadi Faezi; Bahareh Mehramouz; Sepehr Taghizadeh; Pasquale Pagliano; Hossein Samadi Kafil
Journal:  Infez Med       Date:  2022-09-01

2.  Differentiating impacts of non-pharmaceutical interventions on non-coronavirus disease-2019 respiratory viral infections: Hospital-based retrospective observational study in Taiwan.

Authors:  Andrew Po-Liang Chen; Isaac Yen-Hao Chu; Mei-Lin Yeh; Yin-Yin Chen; Chia-Lin Lee; Hsiao-Hsuan Lin; Yu-Jiun Chan; Hsin-Pai Chen
Journal:  Influenza Other Respir Viruses       Date:  2021-04-07       Impact factor: 4.380

3.  Comparison of clinical features and outcomes in COVID-19 and influenza pneumonia patients requiring intensive care unit admission.

Authors:  A Oliva; G Ceccarelli; C Borrazzo; M Ridolfi; G D 'Ettorre; F Alessandri; F Ruberto; F Pugliese; G M Raponi; A Russo; A Falletta; C M Mastroianni; M Venditti
Journal:  Infection       Date:  2021-05-26       Impact factor: 3.553

4.  Which influenza viruses will emerge following the SARS-CoV-2 pandemic?

Authors:  Karen L Laurie; Steve Rockman
Journal:  Influenza Other Respir Viruses       Date:  2021-05-06       Impact factor: 5.606

5.  The impact of the COVID-19 pandemic on influenza, respiratory syncytial virus, and other seasonal respiratory virus circulation in Canada: A population-based study.

Authors:  Helen E Groves; Pierre-Philippe Piché-Renaud; Adriana Peci; Daniel S Farrar; Steven Buckrell; Christina Bancej; Claire Sevenhuysen; Aaron Campigotto; Jonathan B Gubbay; Shaun K Morris
Journal:  Lancet Reg Health Am       Date:  2021-07-17

6.  Trends in respiratory virus circulation following COVID-19-targeted nonpharmaceutical interventions in Germany, January - September 2020: Analysis of national surveillance data.

Authors:  Djin-Ye Oh; Silke Buda; Barbara Biere; Janine Reiche; Frank Schlosser; Susanne Duwe; Marianne Wedde; Max von Kleist; Martin Mielke; Thorsten Wolff; Ralf Dürrwald
Journal:  Lancet Reg Health Eur       Date:  2021-06-07

Review 7.  Effects of COVID-19 prevention procedures on other common infections: a systematic review.

Authors:  Omid Dadras; Seyed Ahmad Seyed Alinaghi; Amirali Karimi; Mehrzad MohsseniPour; Alireza Barzegary; Farzin Vahedi; Zahra Pashaei; Pegah Mirzapour; Amirata Fakhfouri; Ghazal Zargari; Solmaz Saeidi; Hengameh Mojdeganlou; Hajar Badri; Kowsar Qaderi; Farzane Behnezhad; Esmaeil Mehraeen
Journal:  Eur J Med Res       Date:  2021-07-03       Impact factor: 2.175

8.  Low levels of respiratory syncytial virus activity in Europe during the 2020/21 season: what can we expect in the coming summer and autumn/winter?

Authors:  Jojanneke van Summeren; Adam Meijer; Guðrún Aspelund; Jean Sebastien Casalegno; Guðrún Erna; Uy Hoang; Bruno Lina; Simon de Lusignan; Anne C Teirlinck; Valtýr Thors; John Paget
Journal:  Euro Surveill       Date:  2021-07

9.  Expansion of a national Covid-19 alert level system to improve population health and uphold the values of Indigenous peoples.

Authors:  Amanda Kvalsvig; Nick Wilson; Cheryl Davies; Carmen Timu-Parata; Virginia Signal; Michael G Baker
Journal:  Lancet Reg Health West Pac       Date:  2021-07-11

10.  Changes in Influenza and Other Respiratory Virus Activity During the COVID-19 Pandemic - United States, 2020-2021.

Authors:  Sonja J Olsen; Amber K Winn; Alicia P Budd; Mila M Prill; John Steel; Claire M Midgley; Krista Kniss; Erin Burns; Thomas Rowe; Angela Foust; Gabriela Jasso; Angiezel Merced-Morales; C Todd Davis; Yunho Jang; Joyce Jones; Peter Daly; Larisa Gubareva; John Barnes; Rebecca Kondor; Wendy Sessions; Catherine Smith; David E Wentworth; Shikha Garg; Fiona P Havers; Alicia M Fry; Aron J Hall; Lynnette Brammer; Benjamin J Silk
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2021-07-23       Impact factor: 17.586

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.